Market
Scenario:
Intravenous immunoglobulin
(IVIg) is a sterile concentration of antibodies extracted from the plasma of thousands of people to be
administered into patient’s vein. The production of this solution is strictly
based on guidelines established by World Health Organization (WHO) and the
International Union of Immunological Societies (IUIS) which authenticates the
reliability and amplifies its adoption. In the latest report published by
Market Research Future (MRFR), the global market for intravenous immunoglobulin
will reach a valuation of over USD 8 Bn with a CAGR of ~5.9% from 2016 to 2023
(forecast period).
Initially, IVIg was used
for treating thrombocytopenic purpura (ITP) in children. But, with the
advancements in healthcare, it has beneficially affected patients suffering
from diseases such as Kawasaki disease, lupus, Guillain-Barre syndrome,
myositis, multiple sclerosis, etc. With its increasing applications, the market
for IVIg is growing simultaneously. In the present era, the usage of IVIg has
expanded to medicinal sectors such as neurology, hematology, immunology,
nephrology, rheumatology, and, dermatology. Another factor which can propel the
growth of the market is the rare visibility of any side effects from the
treatment. The immediate side effects are chills, flu, etc. Serious side
effects generally occur in patients who
regularly undertake the medication or
take high dosages. Till now, less than 5% has encountered severe side effects.
Some of
the factors that can adversely affect the market growth are
strict regulations, high cost, etc.
Key
Players for Global Intravenous Immunoglobulin (IVIg)
Market:
·
ABEONA
THERAPEUTICS
·
Baxter
·
BDI
Pharma
·
Biotest
AG.
·
China
Biologic Products, Inc.
·
CSL
Behring
·
Grifols
Inc.
·
Kedrion
S.p.A
·
Octapharma
·
Shire
Global
Intravenous Immunoglobulin (IVIg) Market Segmentation:
By type, the global market
for intravenous immunoglobulin has been segmented into IgA, IgD, IgE, IgG, IgM.
By
application, the market is segmented into chronic inflammatory
demyelinating polyneuropathy (CIDP), hypogammaglobulinemia, multifocal motor
neuropathy, immunodeficiency diseases, primary humoral immunodeficiency,
myasthenia gravis (MG), Guillain-Barre Syndrome, Kawasaki disease, ITP, and
others.
Sub segments of
hypogammaglobulinemia are AGM1, AGM2, AGM3, AGM4, AGM5, AGM6.
Sub segments of
immunodeficiency diseases are X-linked agammaglobulinemia (XLA), common
variable immunodeficiency (CVID), severe combined immunodeficiency.
Sub segments of primary
humoral Immunodeficiency are B cell (antibody) deficiencies, T cell
deficiencies, combination B and T cell deficiencies, defective phagocytes,
complement deficiencies, unknown (idiopathic).
Sub segments of myasthenia
gravis are generalized myasthenia gravis, ocular myasthenia gravis, congenital
myasthenia gravis, transient neonatal myasthenia gravis.
Sub segments of the Guillain-Barre syndrome are acute inflammatory
demyelinating polyradiculoneuropathy (AIDP), miller fisher syndrome (MFS), acute motor axonal neuropathy (AMAN) and acute motor-sensory axonal neuropathy (AMSAN).
Sub segments of ITP are
acute and chronic.
Regional Analysis of Global Intravenous
Immunoglobulin (IVIg) Market:
Considering
the global scenario of the market, North America is believed to be the largest
market for Global IVIg. Moreover the European market, especially Western Europe
is growing and second largest market for Global IVIg. On the other hand,
Asia-Pacific is expected to grow at significant rate in the Global IVIg market
during the forecasted period. Middle East and Africa is likely to have a
limited but steady growth in the market, particularly market in North Africa is
growing as compared to South and East region of Africa due to less awareness of
these therapies and treatment.
Detailed Table of Contents:
1. Report Prologue
2. Introduction
2.1
Definition
2.2
Scope Of The Study
2.2.1
Research Objective
2.2.2
Assumptions
2.2.3
Limitations
2.3
Market Structure
2.4.
Market Segmentation
3. Research Methodology
3.1
Research Process
3.2
Primary Research
3.3
Secondary Research
3.4
Market Size Estimation
3.5
Forecast Model
4. Market Dynamics
4.1
Drivers
4.2
Restraints
4.3
Opportunities
4.4
Mega Trends
4.5
Macroeconomic Indicators
5. Market Factor Analysis
5.1
Value Chain Analysis
5.2
Porters Five Forces
5.3
Demand & Supply: Gap Analysis
5.4
Pricing Analysis
5.5
Investment Opportunity Analysis
...Continued
About
US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune -
411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment